This paper compared the effects of a 2 h blood processing delay and post-staining storage on monocyte subsets and monocyte-platelet aggregation in EDTA and sodium citrate anticoagulated blood.
Ji WJ, Lu RY, Liu JX, Ma YQ, Zeng S, Shi R, Zhao JH, Chen SB, Zhou X, Li YM
This paper compared the effects of a 2 h blood processing delay and post-staining storage on monocyte subsets and monocyte-platelet aggregation in EDTA and sodium citrate anticoagulated blood.
Citrated blood had more CD14++CD16-, CD14++CD16+, and CD14+CD16++ monocyte platelet aggregates than EDTA blood when processed immediately and after 2 h. Further, the percentage CD14++CD16+ and CD14++CD16- monocytes and CD14++CD16-, CD14++CD16+, and CD14+CD16++ monocyte-platelet aggregates in citrated blood were significantly affected by pre-processing storage and post-staining storage, but there was no effect of preprocessing storage in EDTA blood and post-staining storage only affected the percentage CD14++CD16+ monocyte platelet aggregates. Although citrated plasma had more monocyte platelet aggregates than EDTA specimens at all time points, the difference increased with post-staining storage and citrated specimens had fewer CD14++CD16- monocytes when stored post-staining for 1 h or more and more CD14++CD16+ monocytes when stored post-staining for 3 h or more compared to EDTA specimens.
This study compared the effect of a 2 h blood processing delay and post-staining storage on monocyte subsets and monocyte-platelet aggregation in EDTA and sodium citrate anticoagulated blood. Blood was collected from 12 healthy donors using a 21-gauge (G) needle and a light tourniquet (discarding the first 3 mL) into tubes containing 3.8% sodium citrate or 2.0 mg/mL EDTA. Specimens were either immediately subjected to red blood cell lysis and staining or stored for 2 h at 4˚C with 10 sec agitation every 30 min. Monocytes were incubated with fluorescently-labeled antibodies against CD14, CD16, CD86, and CD41 and red blood cells were lysed with red blood cell lysis buffer. After lysis and staining, specimens were stored at 4˚C and analyzed 0, 1, 3, and 5 h later by four-color flow cytometry. Viability was determined by 7-aminoactinomycin D staining.
Citrated blood had more CD14++CD16-, CD14++CD16+ and CD14+CD16++ monocyte platelet aggregates than EDTA blood when processed immediately (10.4%, P<0.01; 11.9%, P<0.01; and 8.9%, P<0.05; respectively) and even more so after 2 h (27.8%, P<0.01; 26.9%, P<0.01; and 19.4%, P<0.01; respectively). Storage of citrated blood at 4˚C for 2 before processing resulted in an increase in the percentage of CD14++CD16+ (P<0.01) and a decrease in CD14++CD16- (P<0.01) monocytes as well as an increase in CD14++CD16-, CD14++CD16+, and CD14+CD16++ monocyte-platelet aggregates (P<0.01, all), but had no effect on cell viability or the subset of CD14+CD16++ monocytes. In contrast, storage of EDTA anticoagulated blood had no effect on monocyte subsets, monocyte platelet aggregates, or cell viability. Post-staining storage resulted in a significant trend toward decreasing percentage of CD14++CD16- monocytes (P<0.01), and increasing percentages of CD14++CD16+ monocytes (P<0.01), CD14++CD16 monocyte platelet aggregates (P<0.01), CD14++CD16+ monocyte platelet aggregates (P<0.01), and CD14+CD16++ monocyte platelet aggregates (P<0.01) in citrated specimens and a trend toward increasing CD14++CD16+ monocyte platelet aggregates in EDTA specimens (P<0.05). Although citrated plasma had more monocyte platelet aggregates than EDTA specimens at all time points (P<0.01, all), the difference increased with post-staining storage. Additionally, citrated specimens had fewer CD14++CD16- monocytes when stored post-staining for 1 h or more and more CD14++CD16+ monocytes when stored post-staining for 3 h or more compared to EDTA specimens.
| Classification | Pre-Analytical Factor | Value(s) |
|---|---|---|
| Biospecimen Acquisition | Anticoagulant | EDTA Sodium citrate |
| Storage | Storage duration | 0 h 1 h 2 h 3 h 5 h |